INS and Alzheimer disease: For example, there is some evidence that T2DM, a state of peripheral insulin resistance, is associated with increased Aβ deposition14; however, insulin may be acting through other mechanisms such as by increasing inflammation, oxidative stress, vascular pathology or though altered glucose and lipid metabolism, thereby increasing the likelihood of an AD diagnosis in those with T2DM.